National Health (Pharmaceutical Benefits - Early Supply) Amendment Instrument 2014 (No. 7) - specification under subsection 84AAA(2) (No. PB 84 of 2014)

Link to law: https://www.comlaw.gov.au/Details/F2014L01392

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
 
PB 84 of 2014
National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 7) – specification under subsection 84AAA(2)
 
National Health Act 1953
 
I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 20 October 2014
 
 
 
 
 
 
 
 
 
 
 
FELICITY McNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
 
 
 
___________________________________________________________________________
 
Amendment determination – Pharmaceutical Benefits – Early Supply
 
 
1          Name of Instrument
 
(1)           This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2014 (No. 7) – specification under subsection 84AAA(2).
 
(2)           This Instrument may also be cited as PB 84 of 2014.
 
 
2          Commencement
 
This Instrument commences on 1 November 2014.
 
3          Amendment of PB 30 of 2009
 
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).
 
Schedule 1        Amendments
 
[1]           Schedule 1, after entry for Indacaterol
insert:
Indacaterol with glycopyrronium
Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler)
Inhalation by mouth
30
5